longevityanti-agingimmune-support

Rapamycin

Rapamycin (Sirolimus)

The most studied longevity drug — now available through telehealth

Moderate Preclinical / Emerging HumanPrescription only; available via telehealth

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptides discussed may be research compounds not approved for human use. Always consult a qualified healthcare provider before starting any peptide protocol. Read our full disclaimer →

Quick Reference

Peptide ClassmTOR Inhibitor / Longevity Drug
Half-Life57-63 hours
AdministrationOral
Typical Dosage2-6mg once weekly (longevity protocol)
Cycle LengthOngoing intermittent; typically once weekly
Evidence LevelModerate Preclinical / Emerging Human
Legal StatusPrescription only; available via telehealth
Approximate Cost$50-200/month depending on dose and pharmacy

How Rapamycin Works

Inhibits mTORC1 to activate autophagy, reduce senescent cell accumulation, and rejuvenate immune function

Rapamycin inhibits mTORC1, a master regulator of cell growth and metabolism. mTORC1 inhibition activates autophagy (cellular cleanup), reduces senescent cell accumulation, rejuvenates immune function, and improves metabolic markers. The key insight is that intermittent low-dose use avoids the immunosuppressive effects seen at continuous high doses.

Evidence Base

Preclinical Evidence

Extends lifespan in yeast, worms, flies, and mice. Most replicated longevity intervention in animal models.

Human Evidence

Emerging data from longevity clinics shows immune rejuvenation and metabolic improvements. PEARL trial ongoing.

Anecdotal Evidence

Longevity clinic patients report improved energy, immune resilience, and metabolic markers.

Key PubMed References:

Free Personalized Analysis

Is Rapamycin right for your biology?

Take the 5-minute PeptidePilot quiz to get a personalized peptide match based on your goals, body, and lifestyle. Independent and vendor-neutral.

Safety Profile

Side Effects

At low intermittent doses: mouth sores (canker sores) in some users, mild immunosuppression. Metabolic effects (elevated lipids, insulin resistance) are dose-dependent and less common at longevity doses.

Contraindications

Active infection, pregnancy, known hypersensitivity. Use with caution in immunocompromised individuals. Requires physician supervision.

PeptidePilot Assessment

Rapamycin is PeptidePilot's top recommendation for users whose primary goal is longevity and who are willing to work with a physician on a monitored protocol. It has the strongest evidence base of any longevity compound and is increasingly accessible through telehealth platforms.

📊 6% of PeptidePilot users with longevity as their primary concern receive Rapamycin as their top match

Frequently Asked Questions

Explore More Peptides